You are here

CROI 2020 Review: Dual ART & HIV Cure

graphic image

Presentation slides from the Mountain West AETC's CROI 2020 review (4/9/20) on dual antiretroviral therapy (ART) & HIV cure. Slides review the following:

Dual ART

  • Dolutegravir/lamivudine initial ART: updated 96-week results
  • Islatravir + doravirine metabolic outcomes at 48 weeks

HIV Cure

  • Sustained HIV remission in the London Patient

Add comment

Log in to post comments